Shamburg News · 8-K filed Nov 12, 2026, 4:30 PM EST

Aethlon Medical Reports Q2 Fiscal 2027 Results and Provides Merger Update

AEMD · AETHLON MEDICAL INC

  • Earnings
  • Other event
  • Reg FD disclosure
  • Material agreement
  • Materiality: high

Aethlon Medical, Inc. furnished a November 12, 2026 press release reporting results for the fiscal second quarter ended September 30, 2026. The company reported a net loss of $2,617,507 for the quarter versus $1,487,100 a year earlier, with cash and cash equivalents of approximately $6.5 million at September 30, 2026. The release also describes the proposed merger with North Immunology, Inc. under a September 17, 2026 Plan of Merger and Reorganization, workforce reductions, and a contingent value right to be issued to shareholders at closing.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 7.01, 9.01, accession 0001683168-26-008622.

Written from the filing by Shamburg Markets. Figures are as reported by the company.